TXG 10x Genomics shares rise 308 percent after Q4 2025 EPS outpaces consensus analyst estimates Bone Bio BBLG LongTerm View Q4 2025 EPS Exceeds Expectations How iTonic ITOC balances growth with profitability Grinds Lower 20260511 Muzero MUZE Stock Next Quarter 010 20260420 LESL Leslies misses earnings by 20 as expenses climb shares drop 3 in trading AAOI Applied Opto reports narrower than expected Q4 2025 loss shares rise 754 percent in todays session MNYWW MoneyHero withholds quarterly earnings metrics as it refocuses on nearterm core fintech expansion priorities MMYT MakeMyTrip Limited posts narrow Q1 2026 EPS miss shares edge 069 lower in todays trade EXAS Exact posts far wider than expected Q4 2025 loss shares remain unchanged in todays trading U Power UCAR Climbs 368 Resistance at 148 in Focus 20260514 PGIM GHY Stalls at 1202 Consolidation Phase 20260514 Sprott FUND Falls 085 Watching 941 Support 20260519 Arcosa ACA Slides 163 as Selling Pressure Mounts 20260518 Automation in Apparel How Robotic Sewing Machines Could Reshape Global Textile Supply Chains X Pledges Faster Moderation on Hate and Terror Content in UK After Ofcom Pressure ARKO Q1 2026 Earnings Wide EPS Surprise Despite Negative Bottom Line Mango Faces Leadership Uncertainty as Founders Son Arrested in Fatal Cliff Incident 5E Advanced Materials Inc FEAM Q1 2026 Earnings NarrowerthanExpected Loss as Cost Controls Gain Traction ZD Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Progress CATO Q4 2025 Earnings Reported Loss of 055 Per Share Shares Decline 64 ABVC BioPharma Inc Q1 2025 Earnings Narrowed Loss Highlights Continued Pipeline Progress AWR Q1 2026 Earnings EPS Misses Estimates by 228 Stock Gains 08 COKE CocaCola reports Q4 2025 EPS of 211 dollars shares rise 146 percent on positive investor reception EME EMCOR Group beats Q1 2026 estimates by 149 with EPS of 684 signaling robust specialty construction demand ONEOK Inc OKE The Undervalued LargeCap Midstream Play With Compelling RiskAdjusted Upside How X3 XTKG performance compares to expectations Plummets 20260511 How Tarsus Pharmaceuticals TARS differentiates itself from competitors Underperforming 20260511 Micron Technology MU What Wall Street expects from UroGen Pharma URGN this quarter Q1 2026 EPS Exceeds Expectations UUUU Q1 2026 Earnings NarrowerThanExpected Loss as Uranium Market Remains Subdued